Cancer News and Research

Latest Cancer News and Research

Drugs needed to preserve eggs for reproduction need to be given in stages

Cryoprotectants needed to preserve eggs for reproduction need to be given in stages, albeit rapid ones, say scientists who have developed a mathematical model that predicts optimal time for loading and unloading these drugs.

29 Apr 2009

Finding will improve accuracy of cancer diagnosis

Van Andel Research Institute (VARI) investigators working in collaboration with Cleveland Clinic researchers have determined that two types of kidney tumors previously thought to be different diseases are actually variations of the same disease.

29 Apr 2009

Aspirin for forty somethings could cut cancer risk

Taking aspirin in your 40s could cut the risk of cancer developing later in life, according to research published in the Lancet Oncology.

29 Apr 2009

Anti-viral drug telaprevir improves response, halves duration of hepatitis C treatment

The addition of the anti-viral drug telaprevir to a standard treatment for hepatitis C can shorten the duration of therapy and increase the number of patients who can be cured of their disease, according to the results of study coordinated by investigators from the Duke Clinical Research Institute (DCRI).

29 Apr 2009

SUMO protein guides chromatin remodeler to suppress genes

In an in vitro study, led by Grace Gill, PhD, Tufts University School of Medicine, researchers discovered how a protein called SUMO (Small Ubiquitin-related Modifier) guides an enzyme complex that alters the structure of chromatin to regulate expression of genes.

27 Apr 2009

$Prostate cancer therapy increases risk of fractures and cardiovascular-related death$

Prostate cancer therapy increases risk of fractures and cardiovascular-related death

Prostate cancer patients who undergo therapy to decrease testosterone levels increase their risk of developing bone- and heart-related side effects compared to patients who do not take these medications, according to a new analysis.

27 Apr 2009

Clinical and scientific cooperation to fight lung cancer

Prevention, personalized therapies and closer collaborations between surgeons, medical oncologists and radiation oncologists will result in better outcomes for lung cancer patients and those at risk, a leading European expert says.

27 Apr 2009

Ferring Pharmaceuticals launches new trial of Degarelix for intermittent androgen deprivation therapy

Ferring Pharmaceuticals has announced the launch of a Phase IIIB clinical trial of degarelix for injection, a new injectable gonadotropin-releasing hormone (GnRH) receptor antagonist approved by the U.S. Food and Drug Administration (FDA) for the treatment of hormone sensitive advanced prostate cancer.

27 Apr 2009

Building the lymphatic drainage system

Our bodies' tissues need continuous irrigation and drainage. Blood vessels feeding the tissues bring in the fluids, and drainage occurs via the lymphatic system. While much is known about how blood vessels are built, the same was not true for lymph vessels.

27 Apr 2009

AUA counters mainstream recommendations with new best practice statement on PSA testing

The American Urological Association (AUA) today issued new clinical guidance - which directly contrasts recent recommendations issued by other major groups - about prostate cancer screening, asserting that the prostate-specific antigen (PSA) test should be offered to well-informed, men aged 40 years or older who have a life expectancy of at least 10 years.

27 Apr 2009

Nanotechnology: Its Promise and Challenges - talk by Vicki Colvin

Vicki Colvin of Rice University will give a talk titled "Nanotechnology: Its Promise and Challenges" at the U.S. Department of Energy's Brookhaven National Laboratory on Thursday, May 14, at 4 p.m. in Berkner Hall. The talk is free and open to the public. Visitors to the Laboratory age 16 and older must carry a photo ID.

27 Apr 2009

Green nanotechnology from tea

Researchers from the University of Missouri-Columbia report in the Journal of Materials Chemistry that chemicals in tea are the best yet discovered to make consistent, biologically safe gold nanoparticles. More importantly, these gold nanoparticles show promising anticancer properties.

27 Apr 2009

Coadministration of paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells

Cancer cells, like bacteria, can develop resistance to drug therapy. In fact, research suggests strongly that multidrug-resistant cancer cells that remain alive after chemotherapy are responsible for the reappearance of tumors and the poor prognosis for patients whose cancer recurs.

27 Apr 2009

Nanoscopic 'pearl necklaces' track and attack cancer cells

A team of investigators at Purdue University has developed nanoscale probes that can help pinpoint the location of tumors and might one day be able to directly attack cancer cells.

27 Apr 2009

Hybrid metal and organic nanoparticles for targeting, imaging, and treating cancer

Using a set of three biocompatible polymers and a nanoparticle containing gadolinium, a team of investigators at the Colorado School of Mines has created a nanoparticle platform that has the potential to target, image, and treat cancer.

27 Apr 2009

Nanosensor arrays ''sniff out" cancer

In 2006 researchers established that dogs could detect cancer by sniffing the exhaled breath of cancer patients. Now, using nanoscale arrays of detectors, two groups of investigators have shown that a compact mechanical device also can sniff out lung cancer in humans.

27 Apr 2009

New scan may lead to better treatment for epilepsy

Australian scientists have found that new technology may help in the treatment of epilepsy.

27 Apr 2009

New Federal Government rules on cancer treatment unfair

Critics say new measures proposed by the Australian Federal Government, due to come into force in July this year, will mean an end to Government subsidies for leftover cancer drugs - worth about $26 million a year - are unfair to both patients and pharmacists.

27 Apr 2009

Combination of vitamin E, selenium and soy does not prevent prostate cancer

The combination therapy of vitamin E, selenium and soy does not prevent the progression from high-grade prostatic intraepithelial neoplasia (HGPIN) to prostate cancer, according to the new research presented at the 104th Annual Scientific Meeting of the American Urological Association (AUA).

26 Apr 2009

Cholesterol-lowering drugs may reduce inflammation in prostate tumors

Cholesterol-lowering drugs called statins may reduce inflammation in prostate tumors, possibly hindering cancer growth, according to a study led by investigators in the Duke Prostate Center.

26 Apr 2009